1Tsushima T, Hironaka S, Boku N, et al. Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer[ J]. Gastric Cancer, 2010,13(4): 245-250.
2Nishiyama M, Wada S. Docetaxel: its role in current and future treatments for advanced gastric cancer[ J]. Gastric Cancer, 2009, 12 ( 3 ) : 132 - 141.
3Van-Cutsem E, Moiseyenko V M, Tjulandin S, et al. PhasebⅢ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group [ J ]. J Clin Oncol, 2006, 24 (31 ) :4991 - 4997.
4Kang H, Kauh J S. Chemotherapy in the treatment of metastatic gastric cancer: is there a global standard? [ J]. Curr Treat Options Oncol, 2011, 12(1) : 96 -106.
同被引文献50
1Tsushima T, Hironaka S, Boku N, et al. Safety and efficacy of S- 1 monotherapy in elderly patients with advanced gastric cancer [J]. Gastric Cancer,2010,13(4) :245-250.
2Nishiyama M, Wada S. Docetaxel: its role in current and future treatments for advanced gastric cancer [ J]. Gastric Cancer,2009, 12(3) :132-141.
3Siegel R,Naishadham D,Jemal A. Cancer statistics,2013[J]. CA Cancer J Clin, 2013,63 ( 1 ) : 11-30.
4Jemal A,Bray F,Center MM,et al. Global cancer statistics [J]. CA Cancer J Clin,2011,61(2) :69-90.
5Witkowski ER, Smith JK,Tseng JF. Outcomes following resection of pancreatic cancer[J]. J Surg Oncol, 2013,107( 1 ) : 97-103.
6Siegel R,Ma J,Zou Z,et al. Cancer statistics,2014[J]. CA Can- cer J Clin,2014,64(1) :9-29.
7Tsuchida Y,Therasse P. Response evaluation criteria in solid tu- mors(RECIST) :new guidelines[J]. Med Pediatr Oncol,2001,37 (1):1-3.
8Ueno H,Ioka T,Ikeda M,et al. Randomized phase study of gem- citabine plus S-1,S-1 alone,or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan:GEST study[J]. J Clin Oncol,2013;31(13):1640- 8.
9Kunisaki C,Takahashi M, Makino H,et al. Phase Ⅱ study of bi- weekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer [J]. Cancer Chemother Pharmcol, 2011,67 (6) : 1363-1368.